Amplify Treatments, Testing And Advancements ETF IBRX Holdings History
Amplify Treatments, Testing and Advancements ETF's ImmunityBio Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 64,255.00 shares of ImmunityBio Inc(IBRX), totaling $406,090.00. This investment constitutes 4.45% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0.01% of the outstanding ImmunityBio Inc(IBRX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $6.59 for 28,263.00 shares. Based on historical transaction data and IBRX's current price of $2.72, Amplify Treatments, Testing and Advancements ETF's estimated gain on his IBRX holdings is $-58,079.77, reflecting a -13.86% gain to date.
Amplify Treatments, Testing and Advancements ETF IBRX ($2.72) Holding Chart
Amplify Treatments, Testing and Advancements ETF IBRX ($2.72) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
